AstraZeneca PLC
28 February 2006
Dealing by Directors
Companies Act 1985 Sections 324/329
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DR 3.1.2R
We hereby inform you that on 24 February 2006, the following Directors acquired
an interest in the USD0.25 Ordinary Shares of AstraZeneca PLC. The interest
arises as a result of the previously disclosed arrangements relating to the
payment of annual bonuses for 2005 whereby each individual is required to defer
a portion of the bonus earned into shares for a period of three years. The
shares were allocated at a price of 2639 pence per share. The individuals will
become beneficially entitled to these shares on 24 February 2009.
Number of shares Total interest in shares Percentage of
Name allocated after this allocation shares in issue
J R Symonds 7,534 66,784 0.004%
J S Patterson 6,623 49,071 0.003%
G H R Musker
Company Secretary
28 February 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.